Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 36 studies | 44% ± 20% | |
| astrocyte | 15 studies | 37% ± 14% | |
| connective tissue cell | 13 studies | 45% ± 25% | |
| pericyte | 13 studies | 35% ± 14% | |
| glutamatergic neuron | 12 studies | 36% ± 20% | |
| endothelial cell | 11 studies | 34% ± 16% | |
| smooth muscle cell | 11 studies | 34% ± 13% | |
| oligodendrocyte precursor cell | 11 studies | 43% ± 16% | |
| oligodendrocyte | 11 studies | 26% ± 7% | |
| myofibroblast cell | 7 studies | 41% ± 12% | |
| GABAergic neuron | 6 studies | 37% ± 14% | |
| Mueller cell | 5 studies | 54% ± 26% | |
| interneuron | 5 studies | 30% ± 11% | |
| mesothelial cell | 4 studies | 30% ± 10% | |
| progenitor cell | 3 studies | 38% ± 3% | |
| neuron | 3 studies | 25% ± 11% | |
| endocardial cell | 3 studies | 61% ± 6% | |
| ependymal cell | 3 studies | 36% ± 9% | |
| adventitial cell | 3 studies | 32% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 91% | 1707.19 | 2417 / 2642 | 99% | 21.47 | 700 / 705 |
| lung | 100% | 8424.36 | 578 / 578 | 90% | 23.94 | 1042 / 1155 |
| breast | 96% | 2274.04 | 440 / 459 | 94% | 37.33 | 1048 / 1118 |
| ovary | 100% | 20050.05 | 180 / 180 | 68% | 13.73 | 292 / 430 |
| prostate | 97% | 2997.91 | 237 / 245 | 66% | 8.04 | 331 / 502 |
| bladder | 100% | 4733.43 | 21 / 21 | 59% | 10.63 | 297 / 504 |
| intestine | 84% | 1543.93 | 814 / 966 | 73% | 13.89 | 385 / 527 |
| uterus | 99% | 5226.17 | 169 / 170 | 49% | 11.90 | 227 / 459 |
| stomach | 62% | 1292.91 | 224 / 359 | 81% | 17.84 | 231 / 286 |
| esophagus | 70% | 1179.35 | 1007 / 1445 | 70% | 14.96 | 129 / 183 |
| thymus | 89% | 1716.93 | 583 / 653 | 47% | 8.53 | 285 / 605 |
| skin | 92% | 5755.41 | 1658 / 1809 | 43% | 6.34 | 201 / 472 |
| adrenal gland | 75% | 1080.66 | 193 / 258 | 52% | 9.87 | 120 / 230 |
| kidney | 56% | 1239.89 | 50 / 89 | 55% | 8.63 | 492 / 901 |
| spleen | 100% | 8129.96 | 241 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 6711.10 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 96% | 2820.88 | 1154 / 1204 | 0% | 0 | 0 / 0 |
| pancreas | 6% | 85.42 | 19 / 328 | 89% | 31.78 | 159 / 178 |
| tonsil | 0% | 0 | 0 / 0 | 51% | 6.78 | 23 / 45 |
| heart | 51% | 747.82 | 435 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 41% | 3.48 | 12 / 29 |
| liver | 0% | 5.52 | 1 / 226 | 13% | 1.71 | 54 / 406 |
| muscle | 6% | 86.92 | 51 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.18 | 2 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007043 | Biological process | cell-cell junction assembly |
| GO_0034332 | Biological process | adherens junction organization |
| GO_0050804 | Biological process | modulation of chemical synaptic transmission |
| GO_0007275 | Biological process | multicellular organism development |
| GO_0007155 | Biological process | cell adhesion |
| GO_0044331 | Biological process | cell-cell adhesion mediated by cadherin |
| GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO_0016339 | Biological process | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO_0003189 | Biological process | aortic valve formation |
| GO_0048041 | Biological process | focal adhesion assembly |
| GO_0001501 | Biological process | skeletal system development |
| GO_0030336 | Biological process | negative regulation of cell migration |
| GO_0000902 | Biological process | cell morphogenesis |
| GO_0001503 | Biological process | ossification |
| GO_0021957 | Biological process | corticospinal tract morphogenesis |
| GO_0016477 | Biological process | cell migration |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0005576 | Cellular component | extracellular region |
| GO_0098685 | Cellular component | Schaffer collateral - CA1 synapse |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0016342 | Cellular component | catenin complex |
| GO_0005912 | Cellular component | adherens junction |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0045296 | Molecular function | cadherin binding |
| GO_0008013 | Molecular function | beta-catenin binding |
| GO_0005509 | Molecular function | calcium ion binding |
| Gene name | CDH11 |
| Protein name | Cadherin-11 (OSF-4) (Osteoblast cadherin) (OB-cadherin) Cadherin 11, type 2, OB-cadherin (Osteoblast) Cadherin 11 |
| Synonyms | hCG_26636 |
| Description | FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. Required for proper focal adhesion assembly . Involved in the regulation of cell migration . . FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. . FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. . |
| Accessions | A0A087X227 H3BQH2 H3BUU9 ENST00000567934.5 ENST00000394156.7 [P55287-2] Q96CZ9 H3BR78 P55287 ENST00000566827.5 ENST00000562998.1 ENST00000268603.9 [P55287-1] ENST00000562325.5 ENST00000562712.5 H3BPQ2 H3BSM4 H3BQB5 ENST00000564317.5 H3BP26 ENST00000619158.1 ENST00000562882.5 |